If something worked, what would convince us as scientists, whats meaningful to the general public? Finalists in the Healthspan competition will be announced in August
Medication-Specific Adjustments Guidelines from the FDA and KDIGO-ADA 2022 indicate that liraglutide (Saxenda), semaglutide (Wegovy, Ozempic), and tirzepatide (Zepbound, Mounjaro) do not require dose adjustments for CKD patients
Cycle Length and Continuous Use Clinical trials have safely used AOD-9604 for durations ranging from single doses to 24 weeks of continuous daily administration
Methods Retrospective study utilizing data from a federated research network (TriNetX)
BPC-157 Alternatives Without Theoretical Cancer Risk: Pro-Angiogenic Concerns and Safer Peptide Options BPC-157 promotes blood vessel growth in animal studies, raising theoretical concerns about feeding occult tumors
for example, Candida albicans infection compromises OXPHOS in macrophages, whereas Toxoplasma gondii physically hijacks host mitochondria to scavenge metabolites (Lee et al., 2005